CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BIIB

anti-TNF therapy

Phase 3
Biogen Inc. (BIIB)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Mar '27
BIIBPhase 3

anti-TNF therapy Phase 3 Est. Readout (CRI-RA)

anti-TNF therapy
Mar 2027~
CT.gov
00%
Drug Information

Target Indication

Rheumatoid Arthritis

Clinical Trial

NCT04870203

Last updated: 10/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.